| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/17/2009 | EP2068918A1 Vaccine composition containing synthetic adjuvant |
| 06/17/2009 | EP2068917A2 Compositions and methods for chitosan enhanced immune response |
| 06/17/2009 | EP2068916A1 Vaccines against chlamydial infection |
| 06/17/2009 | EP2068915A2 Combination vaccines with 1-hydroxy-2-phenoxyethane preservative |
| 06/17/2009 | EP2068913A2 Immune modulators, preparations and compositions including immune modulators, tests for evaluating the activity of immune modulators and preparations and compositions including the same, and methods |
| 06/17/2009 | EP2068887A2 Sp35 antibodies and uses thereof |
| 06/17/2009 | EP2068874A1 Methods of treating multiple myeloma using combination therapies based on anti-cs1 antibodies |
| 06/17/2009 | EP2068834A2 Stable powder formulations of aluma-dsorbed vaccines |
| 06/17/2009 | EP1655036A4 Method for treating oncological diseases |
| 06/17/2009 | EP1602669B1 Antibody against a tumor-specific antigen as target |
| 06/17/2009 | EP1409544B1 Human dr4 antibodies and uses thereof |
| 06/17/2009 | EP1358319B1 Live influenza vaccine and method of manufacture |
| 06/17/2009 | EP1015496B1 Divalent anti-t cells immunotoxins and use thereof |
| 06/17/2009 | CN101460195A Methods for treating conditions associated with masp-2 dependent complement activation |
| 06/17/2009 | CN101460194A Myxoma virus mutants for cancer treatment |
| 06/17/2009 | CN101460193A Conjugate vaccines |
| 06/17/2009 | CN101460192A Methods and compositions for vaccination of poultry |
| 06/17/2009 | CN101455840A Composite capable of strengthening anti-tumor immune response |
| 06/17/2009 | CN101455839A Edwardsiella tarda antidiotypic antibody genetic engineering vaccine and preparation method thereof |
| 06/17/2009 | CN101455838A Preparation method of avian infectious brunchitis virus HA antigen |
| 06/17/2009 | CN100500849C Expressing Ompk antigen of outer-membrane protein of Vibrio Harveyi and application as constituent of bacteria |
| 06/17/2009 | CN100500210C Use of il-18 inhibitors in hypersensitivity disorders |
| 06/16/2009 | US7547773 Binding site amino acid sequences for use as targeting agents in immunotherapeutics; antitumor agents; which conforms to human leukocyte antigen (HLA) motifs; immunogens; cytotoxic T lymphocytes; comprises proteases; prostate cancer |
| 06/16/2009 | US7547769 Immunomodulatory constructs and their uses |
| 06/16/2009 | US7547768 Anti-TAT 113 antibodies |
| 06/16/2009 | US7547762 T24 antigen for immunodiagnosis of Taenia solium cysticercosis |
| 06/16/2009 | US7547759 Stimulating cytotoxic T-lymphocytes |
| 06/16/2009 | US7547682 Useful as a candidate for a vaccine against ticks, particularly Ornithodoros moubata, tick-borne infections such as rickettsiosis, filariasis, Q fever, African recurrent fever, or viral encephalitis |
| 06/16/2009 | US7547681 Surface receptor antigen vaccines |
| 06/16/2009 | US7547544 Hybridoma cell line for production of immunoglobulins specific to g protein coupled receptor for use in prevention and treatment of cell proliferative disorders |
| 06/16/2009 | US7547527 Use of probiotic lactic acid bacteria for balancing the skin's immune system |
| 06/16/2009 | US7547515 Eating disorders; measuring obesity receptor (ObR) gene expression by detecting mRNA transcripts |
| 06/16/2009 | US7547509 Viricide polypeptide having >70% sequence identity to native cyanovirin-N and having strategic cysteine and arginine replacements is covalent modified by water-soluble Polyoxyethylene Glycol to extend half-life, reduce toxicity, immunogenicity, improve pharmacokinetics, bioavailability; envelope viruses |
| 06/16/2009 | US7547506 Using 6-carboxyfluorescein labeled mycobacterial amino acid sequences to detect infection; veterinary medicine |
| 06/16/2009 | US7547442 Newcastle disease virus infectious clones, vaccines and new diagnostic assays |
| 06/16/2009 | US7547441 PAI-2 conjugates for the treatment and imaging of cancer |
| 06/16/2009 | US7547440 Derived from Japanese cypress pollen allergen; stimulates lymphocytes; reduce symptoms of pollinosis; immunotherapy and diagnosing spring tree pollinosis (Hay fever) |
| 06/16/2009 | US7547439 Elicit immune response from human lymphocytes when complexed with a major histocompatibility complex molecule type HLA-A2; polypeptide |
| 06/16/2009 | US7547438 CD40-binding activating antibodies |
| 06/16/2009 | US7547437 Kidney or liver fibrosis; using antagonist against the mitogenic vascular endothelial growth factors (zvegf3), such as a monoclonal antibody against zvegf3, receptor binding variants, or antisense agents; antagonist of zvegf3 inhibits cell proliferation; humanized, single-chain antibody |
| 06/16/2009 | US7547436 Receptor specific transepithelial transport of therapeutics |
| 06/16/2009 | CA2476934C Stabilized tnfr-fc composition comprising arginine |
| 06/16/2009 | CA2319437C Methods and reagents for decreasing allergic reactions |
| 06/16/2009 | CA2282727C Cell surface molecule mediating cell adhesion and signal transmission |
| 06/16/2009 | CA2266439C Neutrokine .alpha. |
| 06/16/2009 | CA2158322C Immunoconjugate comprising an anti-egf receptor antibody and interleukin-8 |
| 06/11/2009 | WO2009073648A2 Compositions and methods for regulating entamoeba histolytica function |
| 06/11/2009 | WO2009073628A2 Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof |
| 06/11/2009 | WO2009073594A1 Methods of reducing transplant rejection and cardiac allograft vasculopathy by implanting autologous stem cells |
| 06/11/2009 | WO2009073575A2 Methods for treating induced cellular proliferative disorders |
| 06/11/2009 | WO2009073569A2 Protein formulations and methods of making same |
| 06/11/2009 | WO2009073330A2 Novel vaccines against multiple subtypes of influenza virus |
| 06/11/2009 | WO2009073179A2 Chlamydia antigens |
| 06/11/2009 | WO2009073160A1 Anti-vegf antibodies |
| 06/11/2009 | WO2009073146A2 Use of immunomodulatory compounds for the treatment of transverse myelitis, multiple sclerosis, and other disorders |
| 06/11/2009 | WO2009073133A1 Compositions of toll-like receptor agonists and papillomavirus antigens and uses thereof |
| 06/11/2009 | WO2009073115A1 Combination vegfr2 therapy with mtor inhibitors |
| 06/11/2009 | WO2009073104A2 Simian e adenoviruses sadv-39, -25. 2, -26, -30, -37, and -38 |
| 06/11/2009 | WO2009072767A2 A powerful vaccine composition comprising a lipopeptide and poly i:c as an adjuvant |
| 06/11/2009 | WO2009072660A1 Method for production of antibody |
| 06/11/2009 | WO2009072628A1 Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor |
| 06/11/2009 | WO2009072610A1 Cancer vaccine composition |
| 06/11/2009 | WO2009072604A1 Anti-nr10 antibody and use thereof |
| 06/11/2009 | WO2009072598A1 Therapeutic agent for pruritus |
| 06/11/2009 | WO2009072555A1 Cancer vaccine |
| 06/11/2009 | WO2009071892A2 Method for the detection of dead and dying cells |
| 06/11/2009 | WO2009071696A2 Humanized antibody molecules specific for il-31 |
| 06/11/2009 | WO2009071633A1 Influenza composition |
| 06/11/2009 | WO2009071613A2 Vaccine |
| 06/11/2009 | WO2009071599A1 Immunotherapeutic method for increasing groundnut tolerance in a subject |
| 06/11/2009 | WO2009070957A1 Inhibitor of the interaction between blys and ngr and use thereof |
| 06/11/2009 | WO2009070929A1 A subunit vaccine for aquaculture |
| 06/11/2009 | WO2009070844A1 Method of inhibition of leukemic stem cells |
| 06/11/2009 | WO2009050390A3 Method for producing flu virus |
| 06/11/2009 | WO2009044165A3 Molecular adjuvant |
| 06/11/2009 | WO2009041832A3 Vaccines and vaccine components for inhibition of microbial cells |
| 06/11/2009 | WO2009039246A3 Methods of treating a flaviviridae family viral infection, compositions for treating a flaviviridae family viral infection, and screening assays for identifying compositions for treating a flaviviridae family viral infection |
| 06/11/2009 | WO2009030978A3 Conformers of bacterial adhesins |
| 06/11/2009 | WO2009027752A3 Process for producing hepcidin |
| 06/11/2009 | WO2008140565A3 Use of tumor necrosis factor receptor 14 antagonists for treating psoriasis |
| 06/11/2009 | WO2008076915A8 Treatment of pigs with pcv2 antigen |
| 06/11/2009 | WO2007028106A3 Host cell lines for production of antibody constant region with enhanced effector function |
| 06/11/2009 | WO2006078404A3 Notch1 variants associated with cardiovascular disease |
| 06/11/2009 | WO2005112567A9 Vaginal microbicide |
| 06/11/2009 | WO2002099058A3 KCNMAs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 06/11/2009 | US20090151013 Modified ES cells and ES cell-specific genes |
| 06/11/2009 | US20090149637 Human antibodies derived from immunized xenomice |
| 06/11/2009 | US20090149635 Antibodies to human zcytor17 ligand |
| 06/11/2009 | US20090149413 RORS as Modifiers of the p21 Pathway and Methods of Use |
| 06/11/2009 | US20090149411 Immunostimulatory oligonucleotides with modified bases and methods of use thereof |
| 06/11/2009 | US20090149405 Virus-like particle containing a Dengue virus recombinant replicon |
| 06/11/2009 | US20090149379 Novel use of cytokine inhibitors |
| 06/11/2009 | US20090149339 Methods of Identifying Modulators of Interaction Between PDZ Domain Proteins and PL Proteins |
| 06/11/2009 | US20090148905 Antigen-binding constructs |
| 06/11/2009 | US20090148888 Recombinant toxin fragments |
| 06/11/2009 | US20090148854 Can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 184P1E2 can be used in active or passive immunization |
| 06/11/2009 | US20090148521 Solid oral form of a medicinal preparation and a method for the production thereof |
| 06/11/2009 | US20090148513 Compositions and methods for crystallizing antibodies |
| 06/11/2009 | US20090148507 Chimeric polypeptides containing chemokine domains |
| 06/11/2009 | US20090148505 Novel Antiproliferative Factor and Methods of Use |